Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown?

This scientific commentary refers to ‘Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease’ by Sawamoto et al. (https://doi.org/10.1038/s41586-025-08700-0) and ‘Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease’ by Tabar et al. (https://doi.org/10.1038/s41586-025-08845-y).

Authors

Publication Details

Journal
Apollo (University of Cambridge)
Published
2025-10-03
DOI
https://doi.org/10.17863/cam.124815
Primary Topic
Pluripotent Stem Cells Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown?

Roger A Barker, Malin Parmar
Apollo (University of Cambridge)
Pluripotent Stem Cells Research
article

Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown?

Roger A Barker, Malin Parmar
article en

Abstract

This scientific commentary refers to ‘Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease’ by Sawamoto et al. (https://doi.org/10.1038/s41586-025-08700-0) and ‘Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease’ by Tabar et al. (https://doi.org/10.1038/s41586-025-08845-y).

Apollo (University of Cambridge)
Good health and well-being
Openalex Percentile: Top 34%
Pluripotent Stem Cells Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown? — Roger A Barker, Malin Parmar · Apollo (University of Cambridge) (2025) | TGRS Research Map | TGRS